Editorial

DOI: 10.4244/EIJ-E-24-00029

Role of leaflet modification in TAVI: to prevent coronary obstruction only or potentially a routine practice?

Toby Rogers1,2, MD, PhD; Lior Lupu1, MD, MBA

Over the years, transcatheter aortic valve implantation (TAVI) has been increasingly offered to younger patients. The trend has been driven not only by technological advancement and rigorous clinical trials but also by patient demand for interventions that are less invasive, with lower risk and faster recovery. This is evidenced by the high proportion of patients under the age of 65 who undergo TAVI in the USA despite the guidelines recommending surgical aortic valve replacement (SAVR) in this age group1. Younger patients who undergo TAVI are more likely to require reintervention for bioprosthetic valve failure (BVF). If BVF occurs, treatment options are limited to surgical explant or a second TAVI inside the failed valve (redo-TAVI). Both treatment options carry risks. Explant surgery is associated with high mortality rates (with recent data showing a 30-day mortality rate of 16%2). Redo-TAVI risks coronary obstruction and makes future coronary access more challenging345. This is because when we perform redo-TAVI and deploy a transcatheter heart valve (THV) inside a failed THV, we push the degenerated leaflets of the first valve...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 12
Jun 17, 2024
Volume 20 Number 12
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV14I2A24 Jun 20, 2018
Transcatheter aortic valve implantation: don’t forget the coronary arteries!
Søndergaard L and De Backer O
free

10.4244/EIJV14I3A40 Jun 14, 2018
TAVI: a country for old men. Is this durable?
Mylotte D
free

10.4244/EIJ-E-21-00010 Mar 18, 2022
TAVR under 70: is age just a number?
Ng VG et al
free

10.4244/EIJV9SSA16 Sep 15, 2013
Transcatheter aortic valve update 2013
Bourantas C et al
free

Editorial

10.4244/EIJ-E-23-00012 May 12, 2023
ACURATE neo2: jack of all trades or master of none?
Sinning J
free

10.4244/EIJV11SWA27 Sep 17, 2015
Patient selection for TAVI 2015 - TAVI in low-risk patients: fact or fiction?
Haussig S and Linke A
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved